Akbar Mohammad Hosseini
1, Jafar Majidi
1*, Behzad Baradaran
1*, Mehdi Yousefi
2,11 Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract
Human Toll-like receptors (TLRs) are a family of
transmembrane receptors, which play a key role in both innate and adaptive
immune responses. Beside of recognizing specific molecular patterns that
associated with different types of pathogens, TLRs may also detect a number of
self-proteins and endogenous nucleic acids. Activating TLRs lead to the
heightened expression of various inflammatory genes, which have a protective
role against infection. Data rising predominantly from human patients and
animal models of autoimmune disease indicate that, inappropriate triggering of
TLR pathways by exogenous or endogenous ligands may cause the initiation and/or
perpetuation of autoimmune reactions and tissue damage. Given their important
role in infectious and non-infectious disease process, TLRs and its signaling
pathways emerge as appealing targets for therapeutics. In this review, we
demonstrate how TLRs pathways could be involved in autoimmune disorders and
their therapeutic application.